Alignment Healthcare, Inc. $ALHC Shares Acquired by Voya Investment Management LLC

Voya Investment Management LLC boosted its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 61.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,196,297 shares of the company’s stock after acquiring an additional 1,210,930 shares during the quarter. Voya Investment Management LLC’s holdings in Alignment Healthcare were worth $55,775,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. boosted its holdings in Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares in the last quarter. KBC Group NV acquired a new position in shares of Alignment Healthcare in the second quarter worth about $44,000. Signaturefd LLC boosted its stake in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares in the last quarter. Greenleaf Trust purchased a new stake in shares of Alignment Healthcare during the 2nd quarter worth about $160,000. Finally, Ballentine Partners LLC grew its position in shares of Alignment Healthcare by 10.2% during the 2nd quarter. Ballentine Partners LLC now owns 12,862 shares of the company’s stock valued at $180,000 after acquiring an additional 1,188 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock in a transaction on Monday, December 15th. The stock was sold at an average price of $20.01, for a total value of $2,267,513.19. Following the sale, the president owned 1,667,237 shares in the company, valued at $33,361,412.37. The trade was a 6.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John E. Kao sold 180,000 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $19.02, for a total value of $3,423,600.00. Following the sale, the chief executive officer directly owned 2,346,726 shares of the company’s stock, valued at $44,634,728.52. The trade was a 7.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 842,157 shares of company stock valued at $15,187,475 in the last three months. 7.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ALHC has been the subject of several research analyst reports. UBS Group upped their target price on Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Barclays upped their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, October 31st. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. The Goldman Sachs Group restated a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a research report on Monday, November 3rd. Finally, Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $20.35.

Alignment Healthcare Stock Performance

ALHC opened at $20.42 on Friday. Alignment Healthcare, Inc. has a twelve month low of $10.18 and a twelve month high of $21.06. The firm has a market capitalization of $4.09 billion, a PE ratio of -170.17 and a beta of 1.16. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm’s 50-day moving average price is $17.95 and its 200 day moving average price is $16.00.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The business had revenue of $993.70 million for the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business’s revenue for the quarter was up 43.5% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.14) EPS. As a group, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.